123ArticleOnline Logo
Welcome to 123ArticleOnline.com!
ALL >> General >> View Article

Cordenpharma Invests $900m In Usa & Europe Peptide Expansion

Profile Picture
By Author: Ben Gross
Total Articles: 433
Comment this article
Facebook ShareTwitter ShareGoogle+ ShareTwitter Share

CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technology platform. These transformational plans consist of two major expansion initiatives occurring in parallel in the US and Europe, including both existing facilities and new constructions designed and built according to the pharmaceutical industry's most stringent quality and technical standards for short and long peptide manufacturing, including Biologics License Applications (BLA) requirements.

The US expansion involves bringing additional Peptide capacity to the CordenPharma Colorado site with the planned construction of a new large-scale manufacturing facility, and an additional increase in manufacturing trains in the existing facility. This is the result of rapidly increasing demand in the Diabetes and Obesity Glucagon-like Peptide 1 (GLP-1) agonist medications market, and comes off the back of multiple, long-term, multiyear contracts totaling ~€3bn, with potential upsides.
The European expansion centers on the construction of a new state-of-the-art greenfield ...
... facility, with the aim of creating additional Peptide capacity to serve customers from initial early clinical to late-stage commercial manufacturing. The new site will be located in the heart of Europe, fully-integrated within CordenPharma's existing facility network.

In 2022, CordenPharma was acquired by Astorg, a leading Pan-European private equity firm, and its ambitious growth plans aim to help the company reach their ~€1bn sales mark for its pioneering Peptide Platform, and ~€1.8bn total group revenue by 2028. Upon completion, the new constructions will be fully integrated within its outstanding network of world-class cGMP manufacturing facilities, along with the dedicated technical and regulatory support by expert teams needed to secure innovators' supply chains with small to large-scale fully-integrated services from APIs to Drug Products.

More Information : https://www.techdogs.com/tech-news/pr-newswire/cordenpharma-invests-900m-in-transformational-peptide-platform-expansion-in-the-usa-europe

Total Views: 41Word Count: 280See All articles From Author

Add Comment

General Articles

1. Magento Developers Melbourne: Your Trusted Partner For Magento Web Development
Author: themerchantbuddy

2. How Can E-commerce App Development Help Your Business?
Author: Comfygen

3. The Best Baby Cot Mattress For Summer In Australia: Keep Your Baby Cool And Comfortable !
Author: Milari Organics

4. How Might An Amazon Fba Prep Service Center Help You Streamline Your Business?
Author: 3pshipping6

5. Reviving Artisanal Craftsmanship – Why Handmade Products Matter More Than Ever
Author: Chaitanya Kumari

6. What To Look For In A New York Labor And Employment Law Firm
Author: jewellansing792

7. 50 Years Of Long-lasting Performance
Author: Busch Vacuum Solutions

8. Optimize Healthcare Revenue Cycle: Strategies For Financial Success
Author: Albert brown

9. Offres Exclusives Pour Vos Voyages En Inde Du Nord — Économisez Jusqu’à 30% — Réservez Dès Maintenant!
Author: yatika

10. 200-hour Weekend Yoga Teacher Training Course (yttc) In Bengaluru: A Pathway To Mastery In Yoga
Author: Yogakulam Academy

11. Understanding Patient Behavior: The Importance Of Market Research In Healthcare Marketing
Author: Adomantra

12. Ensuring Safety And Privacy: The Advantages Of Close Protection Services In Dubai
Author: Shancy

13. Thermodynamic Steam Traps: A Compact Solution For Maximum Performance
Author: David John

14. Best Accounting Service In California – Mj Financials
Author: maria jeffery

15. Best Astrologer In Hosahalli
Author: Pandith Keshav Das

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: